Direct-To-OTC Approvals, Line Extensions Replace Switches In 2000
This article was originally published in The Tan Sheet
Executive Summary
Direct-to-OTC drug introductions and line extensions dominated the list of new product rollouts in 2000. The year marked the first time since 1993 that no Rx-to-OTC switches were approved, although FDA reviewed several switch candidates.